- Business
- Bombay Oxygen Investments Limited operates as a non-banking financial company in India without accepting public deposits; it maintains substantial investments in shares, mutual funds, other financial securities and listed equities, generating revenue from dividends, interest and capital gains. Incorporated on October 3, 1960 as Bombay Oxygen Corporation Limited and headquartered at 22/B Mittal Tower in Mumbai, Maharashtra, the company changed its name to Bombay Oxygen Investments Limited effective October 3, 2018, discontinued its legacy manufacturing and supply of industrial gases including oxygen, nitrogen, argon, acetylene and medicinal oxygen effective August 1, 2019, and received a Certificate of Registration as a Non-Banking Financial Institution from the Reserve Bank of India on December 31, 2019. The company serves institutional and retail investors through its investment portfolio focused on diversified financial instruments, with operations primarily in India and promoter holding at approximately 73% as of recent filings; recent developments include board meetings in 2025 approving unaudited quarterly financial results amid volatile net sales such as Rs 29.01 crore in June 2024 and a net loss of Rs 5.22 crore in the September 2025 quarter, alongside the launch of a 100-day Saksham Niveshak campaign per IEPFA circular to recover unpaid dividends, a Rs 35 per share dividend declaration on May 28, 2025 and routine compliance announcements under Regulation 30 of SEBI LODR without reported acquisitions, funding rounds or strategic partnerships in the past 1-2 years.